Beverly Hills Aesthetic Institute has been pre-approved to offer Endolift® in Beverly Hills.
Following a structured review of aesthetic practices in the Los Angeles metro area, MediPrisma LLC has identified your practice as meeting the full set of criteria required for Endolift® provider status.
This invitation is personalized, time-limited, and non-transferable. It gives your practice direct access to the clinical pack, device evaluation pathway, and provisional position on the Beverly Hills provider shortlist.
A new structural treatment tier for Beverly Hills Aesthetic Institute, and exclusive provider positioning in Beverly Hills.
The invitation gives your practice direct access to the evidence pack, device overview, training pathway, and Beverly Hills shortlist review.
Clinical pack
Protocol, published evidence, safety summaries, and patient-positioning materials.
Device evaluation
LASEmaR® 1500 overview, acquisition pathways, and medical-liaison call.
Training pathway
Provider onboarding, protocol review, and clinical implementation planning.
Market position
Shortlist consideration for the Beverly Hills provider territory.
Endolift® is a subdermal 1470nm laser procedure delivering selective adipolysis, immediate tissue contraction, and sustained collagen remodeling through a single-use optical fiber inserted beneath the skin surface. No incisions. Local anesthetic only. Outpatient setting.
Per-session fees in the US market range from $3,000 to $5,500. The procedure does not require a surgical suite, operates under local anesthetic, and uses single-use consumable fibers, yielding a margin profile consistent with premium injectable procedures.
Endolift® invitations are issued to one practice per metropolitan area per cycle. Pre-approved status in Beverly Hills is specific to Beverly Hills Aesthetic Institute and cannot be transferred.
Selected Endolift® results across face, neck, and body indications.
A curated gallery of representative before and after outcomes, presented in a clean carousel that fits the current brand style.
Your practice passed our pre-approval review.
Before extending an invitation, our team conducts a structured review of aesthetic practices in each target area. We assess a defined set of criteria before any practice is shortlisted. Beverly Hills Aesthetic Institute met the threshold across all of the following.
Verified Clinical Credentials
The lead physician holds active board certification or equivalent clinical qualification in an aesthetic or medical specialty.
Established Patient Base
The practice has a documented patient volume consistent with successful integration of a premium procedure tier.
Positive Patient Reputation
Public review profile reflects consistently high patient satisfaction and clinical outcomes across multiple platforms.
Suitable Treatment Environment
The practice operates a compliant clinical facility appropriate for minor outpatient procedures under local anesthetic.
Aesthetic Procedure Portfolio
The practice already offers injectable, laser, or energy-based treatments, indicating an existing patient population suited to Endolift®.
Geographic Availability
No, or very few, other Endolift®-certified providers are currently operating within your immediate service area.
Your invitation is open for 30 more days. Beverly Hills Aesthetic Institute qualifies on every criterion above.
How Endolift® works, a subdermal laser platform that addresses tissue layers no surface-applied device can reach.
The LASEmaR® 1500 delivers 1470nm laser energy via a single-use optical fiber placed subdermally through a micro-entry point. The procedure addresses three simultaneous tissue targets through one session.
A micro-optical fiber delivers 1470nm laser energy through a small entry point.
Thermal effect induces instant tissue contraction and hemostasis.
Neo-collagenesis and elastin remodeling continue over weeks to months.
Improved laxity, contour, and skin quality with minimal downtime.
Why 1470nm Specifically
At 1470nm, laser energy exhibits a water absorption coefficient approximately four times higher than at 980nm and significantly higher than 1064nm. This produces a narrower thermal zone with a steeper absorption gradient, enabling precise subdermal energy delivery.
LASEmaR® 1500
Engineered for precision. Designed for clinical confidence.
The LASEmaR® 1500 is a 1470nm diode laser platform purpose-built for minimally invasive aesthetic procedures.
Most non-surgical aesthetic platforms operate from the surface. Endolift® doesn't.
The treatment gap between injectable procedures and surgical intervention has been underserved by available technology. The table below positions Endolift® relative to the platforms already in your clinic.
| Treatment | Depth of Action | Fat Reduction | Collagen Stimulation | Anesthetic | Downtime |
|---|---|---|---|---|---|
| RF Microneedling | Partial subdermal | Limited | Moderate | Topical | 2 to 5 days |
| HIFU / Ultrasound | Limited subdermal | No | Moderate | None | Minimal |
| Threadlift | Mechanical subdermal | No | Mild | Local | 3 to 7 days |
| External Laser | Surface only | No | Surface only | None | Varies |
| Surgical Facelift | Full subdermal | Partial | Incidental | General / IV | 2 to 4 weeks |
| Endolift® | Targeted subdermal | Yes | Strong, histologically confirmed | Local | 2 to 5 days |
The patients you cannot fully serve today.
Within every established aesthetic practice, there is a patient cohort that presents beyond the ceiling of injectables but below the threshold, psychologically or clinically, for surgical referral. These patients are often highly loyal, treatment-experienced, and commercially valuable.
- The patient between injectable ceiling and surgical threshold
- The post-weight-loss patient with residual pockets and laxity
- The patient who has plateaued on filler and is starting to look over-corrected
- The early surgical candidate not yet ready for rhytidectomy
- The localized fat presentation resistant to conservative measures
- The atrophic acne scarring patient, rolling, boxcar, and icepick subtypes
A premium structural procedure at outpatient operating cost.
The margin profile of Endolift® is determined by three variables: session fee, single-use consumable cost per fiber, and procedure time. The figures below are drawn from current US market data across certified providers.
Endolift® serves a patient cohort your existing menu cannot reach. RF, HIFU, and injectable revenue is not displaced.
The procedure's clinical complexity and device-driven delivery support premium price positioning.
Providing a structural solution retains the treatment-ceiling patient within your practice.
Detailed acquisition options and finance pathways are in the Clinical Pack.
The procedure your patients are already searching for.
Consumer awareness of Endolift® has been driven by international press coverage across the past 24 months. Patient search volume is ahead of provider availability in most US markets.
Google Trends snapshot captured in April 2026, showing elevated U.S. search demand for Endolift® while local certified provider availability remains limited.
Published clinical evidence includes peer-reviewed RCT, observational, and prospective data.
Prospective RCT evaluating Endolift® for facial and neck rejuvenation.
Histological analysis confirms new collagen fiber formation and adipocyte disruption.
Serial biopsy data from treated and control sites.
Safety profile consistent with outpatient delivery and no serious adverse events attributable to the device.
The full clinical evidence package, including all cited studies, methodology summaries, and safety data tables, is included in the Endolift® Clinical Pack.
Histological evidence of neo-collagenesis and elastin deposition is a consistent finding across independently conducted biopsy studies. All claims on this page refer to published data and do not constitute a guarantee of individual outcomes.
What is included with your pre-approved Endolift® provider package.
Why your invitation is time-limited.
MediPrisma LLC issues Endolift® invitations on a rolling review cycle. Each cycle covers a defined geographic area, in this case the greater Beverly Hills metro, with a fixed number of provider slots. Pre-approval is valid for 30 days from issue. After expiration, the slot is released for the next review cycle. Approval in a later cycle is not guaranteed, because invitations are intentionally limited to preserve premium positioning and avoid oversaturating the market ahead of demand.
- Pre-approval is specific to Beverly Hills Aesthetic Institute and cannot be transferred
- One pre-approved invitation per practice per review cycle
- Expired invitations require re-entry to the qualification review
- Future cycles in Beverly Hills are not guaranteed within any specific timeframe
Your Beverly Hills window: 30 days remaining.
Accepting the invitation opens a structured evaluation pathway.
Submission is non-binding. Accepting places your practice on our confirmed contact list and triggers the clinical pack delivery. Nothing beyond that is assumed.
Receive the Clinical Pack
Delivered to your email within minutes. Full procedure overview, evidence summaries, device specifications, and commercial modeling.
Discuss Clinical Fit
Our US Medical Liaison contacts you within one business day. Indication selection, workflow integration, and menu positioning.
Review Acquisition Options
Purchase and finance pathways through Reliant Capital are walked through in detail. No pressure timeline.
Plan Training & Launch
Onboarding includes supervised training, certification, and launch support. First independent patient treatment typically within 3 to 6 weeks.
Talk to the team. Review the evidence. Understand the model. Then decide.
Common questions from medical directors.
Accept your pre-approved Endolift® invitation.
Submit below to confirm interest. You will receive the Clinical Pack within minutes, a direct call from our US Medical Liaison within one business day, and provisional reservation of Beverly Hills Aesthetic Institute’s position on the Beverly Hills shortlist for 7 days.
For Medical Professionals only · Submission is non-binding · Your information is held by MediPrisma LLC and used solely to coordinate your Endolift® onboarding.